Trade Summary

Yesterday, Khan Najat, serving as CEO and President at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 23,588 shares at $3.58 per share, for a total transaction value of $84,459.19. Following this transaction, Khan Najat now holds 2,175,796 shares of RXRX.

This sale represents a 1.07% decrease in Khan Najat's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 5:02 PM ET, meaning the disclosure happened on the same day as the trade.

RECURSION PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.